Literature DB >> 21798390

Pollen extract for chronic prostatitis-chronic pelvic pain syndrome.

Florian M E Wagenlehner1, Thomas Bschleipfer, Adrian Pilatz, Wolfgang Weidner.   

Abstract

Prostatitis syndrome is a frequent condition in men. It is not known in most patients if the prostate is the only organ involved. Therefore, the disease is characterized as chronic prostatitis-chronic pelvic pain syndrome (CP-CPPS). Although many studies have been performed in patients with CP-CPPS, current trial evidence is conflicting and therapeutic options are controversial. Given the need for long-term treatment in CP-CPPS patients, phytotherapeutics, such as pollen extract, are an option due to few side effects. Preclinical studies on pollen extract have shown effects on smooth muscles of the bladder and urethra, strong antiinflammatory effects, and antiproliferative effects.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21798390     DOI: 10.1016/j.ucl.2011.04.004

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  7 in total

1.  Immunostimulation in chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): a one-year prospective, double-blind, placebo-controlled study.

Authors:  Florian M E Wagenlehner; Stefania Ballarini; Kurt G Naber
Journal:  World J Urol       Date:  2014-01-31       Impact factor: 4.226

Review 2.  Alternative therapies in the management of chronic prostatitis/chronic pelvic pain syndrome.

Authors:  Amin S Herati; Robert Miles Moldwin
Journal:  World J Urol       Date:  2013-06-06       Impact factor: 4.226

Review 3.  Complementary and alternative treatments for chronic pelvic pain.

Authors:  Adam J Carinci; Ravi Pathak; Mark Young; Paul J Christo
Journal:  Curr Pain Headache Rep       Date:  2013-02

4.  The Clinical Efficacy of Pollen Extract and Vitamins on Chronic Prostatitis/Chronic Pelvic Pain Syndrome Is Linked to a Decrease in the Pro-Inflammatory Cytokine Interleukin-8.

Authors:  Tommaso Cai; Paolo Verze; Roberto La Rocca; Alessandro Palmieri; Daniele Tiscione; Lorenzo Giuseppe Luciani; Sandra Mazzoli; Vincenzo Mirone; Gianni Malossini
Journal:  World J Mens Health       Date:  2017-04-30       Impact factor: 5.400

5.  Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract Plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study.

Authors:  Lucia Muraca; Antonio Scuteri; Elisabetta Burdino; Gianmarco Marcianò; Vincenzo Rania; Luca Catarisano; Alessandro Casarella; Erika Cione; Caterina Palleria; Manuela Colosimo; Antonio Cutruzzolà; Cristina Vocca; Emanuele Basile; Rita Citraro; Gabriella Marsala; Giulio Di Mizio; Giovambattista De Sarro; Luca Gallelli
Journal:  Life (Basel)       Date:  2022-06-27

6.  Allergen Microarrays for In Vitro Diagnostics of Allergies: Comparison with ImmunoCAP and AdvanSure.

Authors:  Hyunjin Jeon; Joo Hyun Jung; Yoonji Kim; Youngeun Kwon; Seon Tae Kim
Journal:  Ann Lab Med       Date:  2018-07       Impact factor: 3.464

Review 7.  The role of flower pollen extract in managing patients affected by chronic prostatitis/chronic pelvic pain syndrome: a comprehensive analysis of all published clinical trials.

Authors:  Tommaso Cai; Paolo Verze; Roberto La Rocca; Umberto Anceschi; Cosimo De Nunzio; Vincenzo Mirone
Journal:  BMC Urol       Date:  2017-04-21       Impact factor: 2.264

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.